AMWL
American Well Corp
$9.11
-0.55%
$152.2M
No data for this timeframe.
Vol
Market Cap$152.2M
Cap SizeMicro Cap
Analyst ConsensusHold (40%)
Inst. Holders28 funds
Inst. Value$16.6M
Inst. Activity1 buys / 1 sells
Insider Activity1B / 10S
Insider Net $-$276.4K
SEC Reports8
Press Releases1
Recent Activity
Jun 9, 2026
SEC
American Well filed a DEFA14A supplement to its 2026 proxy statement, announcing that co-founder Dr. Roy Schoenberg will
DEFA14A — Impact 3/10
Jun 3, 2026
SEC
Two insiders at American Well Corp sold a combined $36K in open-market sales on June 1, 2026. The total value is immater
CLUSTER — Impact 2/10
Jun 1, 2026
SEC
Mark Hirschhorn, an officer of American Well Corp, filed a Form 144 to sell 10,761 Class A common shares (~$105K at the
144 — Impact 2/10
Jun 1, 2026
Insider
Gotlib Phyllis sold 3,573 shares
President, International @ $9.74 ($34.8K)
Jun 1, 2026
Insider
McNeice Paul Francis sold 112 shares
Chief Accounting Officer @ $9.74 ($1.1K)
Jun 1, 2026
Insider
HIRSCHHORN MARK sold 10,761 shares
Chief Financial Officer @ $9.74 ($104.8K)
Inst.
MARSHALL WACE, LLP — TRIM
44,045 shares ($231.7K)
Inst.
PRICE T ROWE ASSOCIATES — ADD
21,998 shares ($116.00)
Price Targets
$7.50
-17.7% upside
Strong Sell
Current $9.11
Low $6.50
Median $7.50
High $9.00
5 analysts
$6.50
$9.00
Analyst Ratings
2Strong Buy
4Buy
9Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 6, 2026 | TD Cowen | MAINTAIN | Hold → Hold |
| May 6, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight → Equal-Weight |
| Feb 13, 2026 | Stifel | MAINTAIN | Hold → Hold |
| Dec 18, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.60 ▲ +22.1% | $-0.60 — $-0.60 | 17% YoY | 1 |
| Next Q | $-0.62 ▲ +11.4% | $-0.62 — $-0.62 | 60% YoY | 1 |
| Current FY | $-2.68 ▲ +6.9% | $-2.68 — $-2.68 | 16% YoY | 1 |
| Next FY | $-1.68 ▲ +15.2% | $-1.68 — $-1.68 | 37% YoY | 1 |
Latest Reports
NEUTRAL
DEFA14A
3/10
American Well filed a DEFA14A supplement to its 2026 proxy statement, announcing that co-founder Dr. Roy Schoenberg will
Jun 9, 2026
NEUTRAL
CLUSTER
2/10
Two insiders at American Well Corp sold a combined $36K in open-market sales on June 1, 2026. The total value is immater
Jun 3, 2026
BULLISH
Press
6/10
Amwell announced results from a large NIH-funded randomized trial published in Nature Human Behaviour, showing SilverClo
May 18, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $6.1M | NEW |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.0M | — |
| BlackRock, Inc. | $2.1M | ADD |
| RENAISSANCE TECHNOLOGIES LLC | $1.0M | — |
| TWO SIGMA INVESTMENTS, LP | $699.6K | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Gotlib Phyllis | SELL | $34.8K |
| Jun 1, 2026 | McNeice Paul | SELL | $1.1K |
| Jun 1, 2026 | HIRSCHHORN MARK | SELL | $104.8K |
| May 7, 2026 | Schoenberg Ido | BUY | $4.9K |
| Apr 1, 2026 | McNeice Paul | SELL | $2.0K |
28 institutional holders with $16.6M total value (3,184,261 shares) as of 2026-Q1. Top holders: MORGAN, VANGUARD, BlackRock,.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 1,156,453 | $6.1M | 36.6% | NEW |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 567,271 | $3.0M | 17.9% | — |
| 3 | BlackRock, Inc. | 391,379 | $2.1M | 12.4% | ADD +46.7% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 195,023 | $1.0M | 6.2% | — |
| 5 | TWO SIGMA INVESTMENTS, LP | 133,009 | $699.6K | 4.2% | DOUBLED +135.1% |
| 6 | GOLDMAN SACHS GROUP INC | 123,597 | $650.1K | 3.9% | — |
| 7 | DIMENSIONAL FUND ADVISORS LP | 88,996 | $468.1K | 2.8% | ADD +36.0% |
| 8 | VANGUARD FIDUCIARY TRUST CO | 79,931 | $420.4K | 2.5% | — |
| 9 | STATE STREET CORP | 56,599 | $297.7K | 1.8% | — |
| 10 | CITADEL ADVISORS LLC | 49,288 | $259.3K | 1.6% | — |
| 11 | HSBC HOLDINGS PLC | 46,565 | $253.8K | 1.5% | DOUBLED +186.6% |
| 12 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 45,400 | $238.8K | 1.4% | — |
| 13 | MARSHALL WACE, LLP | 44,045 | $231.7K | 1.4% | TRIM -49.6% |
| 14 | HighTower Advisors, LLC | 37,659 | $198.1K | 1.2% | — |
| 15 | CITADEL ADVISORS LLC | 34,200 | $179.9K | 1.1% | — |
| 16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31,386 | $165.1K | 1.0% | — |
| 17 | BARCLAYS PLC | 24,047 | $126.5K | 0.8% | DOUBLED +229.9% |
| 18 | WELLS FARGO & COMPANY/MN | 18,665 | $98.2K | 0.6% | TRIM -37.5% |
| 19 | CITADEL ADVISORS LLC | 18,400 | $96.8K | 0.6% | — |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,700 | $72.1K | 0.4% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | TRIM | 87,447 | 44,045 | -49.6% | $231.7K | 2026-Q1 |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | 15,498 | 21,998 | +41.9% | $116.00 | 2026-Q1 |
| BlackRock, Inc. | ADD | 276,740 | 405,892 | +46.7% | $2.0M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 46,329 | 108,940 | +135.1% | $534.9K | 2025-Q4 |
| MARSHALL WACE, LLP | ADD | 49,429 | 87,447 | +76.9% | $429.4K | 2025-Q4 |
| HSBC HOLDINGS PLC | DOUBLED | 16,249 | 46,565 | +186.6% | $224.0K | 2025-Q4 |
| Connor, Clark & Lunn Investment Management Ltd. | TRIM | 15,627 | 10,429 | -33.3% | $51.2K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 1,127 | 4,668 | +314.2% | $22.9K | 2025-Q4 |
| DIMENSIONAL FUND ADVISORS LP | ADD | 71,584 | 97,382 | +36.0% | $598.9K | 2025-Q3 |
| MARSHALL WACE, LLP | ADD | 25,413 | 49,429 | +94.5% | $304.0K | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | TRIM | 26,657 | 16,651 | -37.5% | $102.4K | 2025-Q3 |
| Connor, Clark & Lunn Investment Management Ltd. | ADD | 10,004 | 15,627 | +56.2% | $96.1K | 2025-Q3 |
| Invesco Ltd. | TRIM | 20,052 | 14,426 | -28.1% | $88.7K | 2025-Q3 |
| BARCLAYS PLC | DOUBLED | 4,348 | 14,342 | +229.9% | $88.2K | 2025-Q3 |
| UBS Group AG | TRIM | 10,948 | 4,448 | -59.4% | $27.4K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 469 | 1,127 | +140.3% | $6.9K | 2025-Q3 |
| FMR LLC | NEAR_EXIT | 631 | 59 | -90.6% | $363.00 | 2025-Q3 |
| DIMENSIONAL FUND ADVISORS LP | ADD | 44,620 | 71,584 | +60.4% | $635.9K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 10,205 | 37,776 | +270.2% | $335.8K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 12,118 | 26,657 | +120.0% | $237.0K | 2025-Q2 |
| MARSHALL WACE, LLP | NEAR_EXIT | 106,131 | 25,413 | -76.1% | $225.9K | 2025-Q2 |
| Invesco Ltd. | TRIM | 27,025 | 20,052 | -25.8% | $178.3K | 2025-Q2 |
| UBS Group AG | NEAR_EXIT | 48,988 | 10,948 | -77.7% | $97.3K | 2025-Q2 |
| MARSHALL WACE, LLP | DOUBLED | 18,007 | 106,131 | +489.4% | $836.3K | 2025-Q1 |
| UBS Group AG | ADD | 32,993 | 48,988 | +48.5% | $386.0K | 2025-Q1 |
5 unique insiders with 15 transactions. Net insider value: -$276.4K ($4.9K bought, $281.4K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Gotlib Phyllis | President, International | SELL | 3,573 | $9.74 | $34.8K |
| Jun 1, 2026 | McNeice Paul Francis | Chief Accounting Officer | SELL | 112 | $9.74 | $1.1K |
| Jun 1, 2026 | HIRSCHHORN MARK | Chief Financial Officer | SELL | 10,761 | $9.74 | $104.8K |
| May 7, 2026 | Schoenberg Ido | Chairman, co-CEO | BUY | 670 | $7.37 | $4.9K |
| Apr 1, 2026 | McNeice Paul Francis | Chief Accounting Officer | SELL | 383 | $5.30 | $2.0K |
| Apr 1, 2026 | Zamansky Dmitry | Chief Product & Tech. Officer | SELL | 5,575 | $5.30 | $29.5K |
| Apr 1, 2026 | Gotlib Phyllis | President, International | SELL | 3,706 | $5.30 | $19.6K |
| Mar 4, 2026 | McNeice Paul Francis | Chief Accounting Officer | AWARD | 8,066 | — | — |
| Mar 4, 2026 | HIRSCHHORN MARK | Chief Financial Officer | AWARD | 50,413 | — | — |
| Mar 4, 2026 | Gotlib Phyllis | President, International | AWARD | 50,413 | — | — |
| Mar 4, 2026 | Zamansky Dmitry | Chief Product & Tech. Officer | AWARD | 50,413 | — | — |
| Mar 2, 2026 | Gotlib Phyllis | President, International | SELL | 3,573 | $5.24 | $18.7K |
| Mar 2, 2026 | McNeice Paul Francis | Chief Accounting Officer | SELL | 130 | $5.24 | $681.20 |
| Mar 2, 2026 | HIRSCHHORN MARK | Chief Financial Officer | SELL | 10,796 | $5.24 | $56.6K |
| Mar 2, 2026 | Zamansky Dmitry | Chief Product & Tech. Officer | SELL | 2,472 | $5.45 | $13.5K |
8 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 1 mixed, 6 neutral. Avg impact: 3.3/10.
NEUTRAL
DEFA14A
3/10
American Well filed a DEFA14A supplement to its 2026 proxy statement, announcing that co-founder Dr.
Jun 9, 2026
NEUTRAL
CLUSTER
2/10
Two insiders at American Well Corp sold a combined $36K in open-market sales on June 1, 2026. The to
Jun 3, 2026
NEUTRAL
144
2/10
Mark Hirschhorn, an officer of American Well Corp, filed a Form 144 to sell 10,761 Class A common sh
Jun 1, 2026
NEUTRAL
8-K
3/10
Co-founder and Executive Vice Chairman Dr. Roy Schoenberg resigned from the board effective May 6, 2
May 12, 2026
MIXED
8-K
5/10
Amwell reported Q1 2026 revenue of $54.9M (down 18% YoY) but beat consensus estimates on both EPS ($
May 5, 2026
NEUTRAL
DEFA14A
3/10
American Well Corp (AMWL) has filed a definitive proxy statement (DEFA14A) for its 2026 annual meeti
Apr 23, 2026
BEARISH
CLUSTER
5/10
Multiple C-suite executives at American Well Corp, including the CFO and Chief Product & Technology
Mar 6, 2026
NEUTRAL
CLUSTER
3/10
Two corporate insiders at American Well Corp sold shares in the past week, including the Chief Accou
Mar 3, 2026
Current analyst consensus: Hold (40% buy). Based on 15 analysts: 2 strong buy, 4 buy, 9 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$7.50 mean target
-17.7% upside
Strong Sell (2.71)
$6.50 Low
$9.00 High
| Metric | Value |
|---|---|
| Current Price | $9.11 |
| Target Low | $6.50 |
| Target Mean | $7.50 |
| Target Median | $7.50 |
| Target High | $9.00 |
| # Analysts | 5 |
| Recommendation | Strong Sell (2.71) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.60 | $-0.60 | $-0.60 | 17.0% | +22.1% | 1↑ 0↓ | $0.0B | -29.6% | 1 |
| Next Q 2026-09-30 |
$-0.62 | $-0.62 | $-0.62 | 60.0% | +11.4% | 1↑ 0↓ | $0.0B | -15.7% | 1 |
| Current FY 2026-12-31 |
$-2.68 | $-2.68 | $-2.68 | 16.0% | +6.9% | 1↑ 0↓ | $0.2B | -18.9% | 1 |
| Next FY 2027-12-31 |
$-1.68 | $-1.68 | $-1.68 | 37.3% | +15.2% | 1↑ 0↓ | $0.2B | 3.1% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.600 | |
| 7d ago | $-0.770 | +0.170 |
| 30d ago | $-0.770 | +0.170 |
| 60d ago | $-0.770 | +0.170 |
| 90d ago | $-1.530 | +0.930 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 6, 2026 | TD Cowen | MAINTAIN | Hold | Hold |
| May 6, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 13, 2026 | Stifel | MAINTAIN | Hold | Hold |
| Dec 18, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| May 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Apr 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Mar 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Feb 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Jan 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 18, 2026
fda
Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale
<p>BOSTON, May 18, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=fRZQnsCjeFac8ufiWWTs62dWS_MZ3BU8yCcpjSKqhEMAFncVrNDw
May 5, 2026
earnings
Amwell® Announces Results for First Quarter 2026
<p>BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=tFFAvXnd3WkJVwnWikUOIXw5-jSb0y042yFaoRaecA4MmDobKach
May 5, 2026
earnings_calendar
AMWL Q1 2026 Earnings After Market Close — 2026-05-05
Apr 29, 2026
earnings_calendar
AMWL Q1 2026 Earnings After Market Close — 2026-04-29